Impact of Glycemia on Survival of Glioblastoma Patients Treated With Radiation and Temozolomide

Journal of Neuro-Oncology- Netherlands

doi 10.1007/s11060-015-1815-0

Full Text

Abstract

Available in

Date

May 27, 2015

Authors

Publisher

Springer Science and Business Media LLC

Related search

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Turk Onkoloji Dergisi

Oncology

2019

English

Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma

New England Journal of Medicine

Medicine

2017

English

Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-Based Study

Oncotarget

Oncology

2017

English

Immunosuppression in Patients With High-Grade Gliomas Treated With Radiation and Temozolomide

Clinical Cancer Research

Cancer Research

Oncology

2011

English

Impact on Radiation Dose and Volume V57 Gy of the Brain on Recurrence and Survival of Patients With Glioblastoma Multiformae

Radiology and Oncology

English

The Potential Impact of Delayed Radiation Therapy on Patients With Glioblastoma

Canadian Journal of Neurological Sciences

Medicine

Neurology

2013

English

Comparison of ADC Metrics and Their Association With Outcome for Patients With Newly Diagnosed Glioblastoma Being Treated With Radiation Therapy, Temozolomide, Erlotinib and Bevacizumab

Journal of Neuro-Oncology

English

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT)

International Journal of Radiation Oncology Biology Physics

English

The Prolonged Use of Temozolomide in Glioblastoma Patients

JBNC - JORNAL BRASILEIRO DE NEUROCIRURGIA

2018

English

Amanote Research

Impact of Glycemia on Survival of Glioblastoma Patients Treated With Radiation and Temozolomide

Journal of Neuro-Oncology- Netherlands

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Late Radiation Outcomes of Patients With Newly Diagnosed Glioblastoma Treated With Accelerated Hyperfractionated Radiotherapy and Temozolomide

Short-Course Radiation Plus Temozolomide in Elderly Patients With Glioblastoma

Survival Benefit of Glioblastoma Patients After FDA Approval of Temozolomide Concomitant With Radiation and Bevacizumab: A Population-Based Study

Immunosuppression in Patients With High-Grade Gliomas Treated With Radiation and Temozolomide

Impact on Radiation Dose and Volume V57 Gy of the Brain on Recurrence and Survival of Patients With Glioblastoma Multiformae

The Potential Impact of Delayed Radiation Therapy on Patients With Glioblastoma

Comparison of ADC Metrics and Their Association With Outcome for Patients With Newly Diagnosed Glioblastoma Being Treated With Radiation Therapy, Temozolomide, Erlotinib and Bevacizumab

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT)

The Prolonged Use of Temozolomide in Glioblastoma Patients